S&P Futures
4,598.00 -2.75 (-0.06%) Dow Futures
36,296.00 -7.00 (-0.02%) Nasdaq Futures
15,993.50 -30.25 (-0.19%) Russell 2000 Futures
1,867.50 +1.80 (+0.10%) Crude Oil
74.49 +0.42 (+0.57%) Gold
2,092.30 +2.60 (+0.12%)
EDAP Dec 2023 12.500 call
| Previous Close | 1.5000 |
| Open | 1.5000 |
| Bid | 0.2500 |
| Ask | 1.1000 |
| Strike | 12.50 |
| Expire Date | 2023-12-15 |
| Day's Range | 1.5000 - 1.5000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 31 |
GlobeNewswireEDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
LYON, France, November 30, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that is has received the Industry Category Award from the French National Institute for Intellectual Property (INPI) based on the Company’s innovative therapeutic ultrasound technology. On November 23, 2023, the jury for the 2023 edition of the INPI Trophies honored five companies at an awards ceremony in Paris, which spanned five different categories: Expo
- GlobeNewswire
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Piper Sandler 35th Annual Healthcare Conference, which is being held November 28-30, 2023, in New York, New York. Presentation details: Date:Wednesday, November 29Time:11:00 – 11:25 AM ET Location:The Lotte New York PalaceWebcast:Li
Simply Wall St.EDAP TMS S.A.'s (NASDAQ:EDAP) top owners are individual investors with 56% stake, while 29% is held by institutions
Key Insights The considerable ownership by individual investors in EDAP TMS indicates that they collectively have a...
